Complications and Functional Results of Surgery for Locally Advanced Prostate Cancer

Table 1

Patient characteristics.

Number of patients	139
Age (years), mean (±SD)	61,8 (±7,0)
cT3a	89,9% (𝑛=125)
cT3b	10,1% (𝑛=14)
Biopsy Gleason score, median (range)	7 (2–10)
PSA (ng/mL), mean (range)	13,73 (3,1–97,0)
Previous surgery	14,4% (𝑛=20)
Neo-Adjuvant Androgen Deprivation Therapy	8,6% (𝑛=12)
Non-nerve-sparing procedure	92,8% (𝑛=129)
Unilateral nerve sparing procedure	7,2% (𝑛=10)
Lymphadenectomy not performed	7,2% (𝑛=10)
Hospital stay (days), median (range)	12 (5–27)
pT2	31,1% (𝑛=42)
pT3a	51,1% (𝑛=69)
pT3b	16,3% (𝑛=22)
pT4	1,5% (𝑛=2)
PSA persistence	10,1% (𝑛=14)
Pathological Gleason score, median (range)	7 (4–9)
Pathological node positive	10,1% (𝑛=14)
Surgical margin positive	13,7% (𝑛=19)
Adj radiation therapy within 1 year	7,2% (𝑛=10)
Adj endocrine therapy within 1 year	13,7% (𝑛=19)